Randomized, open label, controlled clinical trial of oral administration of an egg albumin-based protein supplement to patients on continuous ambulatory peritoneal dialysis.

What Was Tested

Researchers studied Albumins in this randomized controlled trial publication.

Therefore, the aim of this study was to evaluate the effect of oral administration of an egg albumin-based protein supplement on the nutritional status of CAPD patients.

Who Took Part

The study group was 28 patients.

The age groups tagged for this paper are middle-aged adults, both men and women.

In this randomized, open label, controlled clinical trial, 28 CAPD patients were allocated to a study (n = 13) or a control (n = 15) group.

Both groups received conventional nutritional counseling; the study group received, additionally, an oral egg albumin-based supplement.

How the Study Was Run

In design terms this was a randomized and open-label study.

The patients were allocated by chance, so the Albumins group and the comparison group should start out alike.

Everyone knew when Albumins was being given (open label), which is simpler to run but leaves more room for expectations to affect what is reported.

What Was Measured

PubMed files the paper under topics including Albumins, Dietary Proteins, Dietary Supplements, Eggs, Peritoneal Dialysis, Continuous Ambulatory and Protein-Energy Malnutrition.

What This Means in Plain Language

The paper is a randomized and open-label study of Albumins in 28 patients.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The abstract goes on to report its results in about 9 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2005 (Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis), a journal based in United States.

More context: all human trials.